Streetbeat News

Stock Prices

JZ

Jianzhi Education Technology has received a non-compliance notice from Nasdaq for failing to meet the $5 million market value requirement over 30 consecutive business days.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:11 pm

IMRX

Immuneering shares are trading higher after the company announced that IMM-1-104 was granted Fast Track designation from the FDA.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:11 pm

APA

APA Corporation (NASDAQ: APA) reported strong Q2 earnings, with adjusted EPS of $1.17 beating the estimate of $1.08 and sales of $2.79 billion surpassing the $2.37 billion estimate. This represents significant year-over-year growth in both earnings and sales.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:11 pm

BALY

Ballys (NYSE:BALY) reported Q2 2024 GAAP EPS of $(1.24), beating the $(1.30) estimate, but sales of $621.657M missed the $639.483M estimate. Sales increased by 2.55% year-over-year.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:10 pm

CDNA

CareDx shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:10 pm

PAYC

Paycom Software, Inc. (NYSE:PAYC) has increased and extended its stock repurchase plan, making $1.5 billion available for repurchases through August 15, 2026. Previously, $676 million was available for repurchases.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:10 pm

GRBK

Green Brick Partners (NYSE:GRBK) reported strong Q2 2024 earnings, with GAAP EPS of $2.32 beating the $1.74 estimate and sales of $560.631M surpassing the $502.637M estimate. This represents significant year-over-year growth in both earnings and sales.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:10 pm

ERII

Energy Recovery has reaffirmed its full-year revenue guidance, projecting revenues between $140 million and $150 million.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:10 pm

BMEA

Biomea Fusion (NASDAQ:BMEA) reported Q2 losses of $(1.03) per share, beating the analyst consensus estimate of $(1.07) by 3.74%. This represents a 47.14% increase in losses compared to $(0.70) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:09 pm

OCGN

Ocugen shares are trading lower following the company's announcement of an underwritten public offering.

Portfolio Pulse from Benzinga Newsdesk

July 31, 2024 | 9:08 pm